UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pre‐treatment total metabolic tumour volumes in lymphoma: Does quantity matter?

British journal of haematology, 2022-04, Vol.197 (2), p.139-155

2022

Volltextzugriff (PDF)

Bone health and glucocorticoid‐containing lymphoma therapy — a review of risk factors and preventative measures

British journal of haematology, 2022-08, Vol.198 (3), p.431-442

2022

Volltextzugriff (PDF)

Late relapses in Hodgkin lymphoma – should we search for the needle in the haystack?

British journal of haematology, 2022-07, Vol.198 (1), p.11-13

2022

Volltextzugriff (PDF)

Routine imaging for disease surveillance in follicular lymphoma—To comfort the patients or their doctors?

Cancer, 2021-09, Vol.127 (18), p.3298-3301

2021

Volltextzugriff (PDF)

Mantle cell lymphoma — where precision medicine based on response‐adapted treatment strategies could show its full worth

British journal of haematology, 2020-05, Vol.189 (4), p.600-602

2020

Volltextzugriff (PDF)

Long‐term cause‐specific mortality in adolescent and young adult Hodgkin lymphoma patients treated with contemporary regimens—A nationwide Danish cohort study

British journal of haematology, 2024-10, Vol.205 (4), p.1374-1382

2024

Volltextzugriff (PDF)

Primary gastric diffuse large B‐cell lymphoma: A multicentre retrospective study

British journal of haematology, 2024-08, Vol.205 (2), p.534-541

2024

Volltextzugriff (PDF)

Detecting deviations from the efficacy and safety results of single‐arm trials using real‐world data: The case of a CAR‐T cell therapy in B‐cell lymphoma

Pharmacoepidemiology and drug safety, 2021-04, Vol.30 (4), p.514-519

2021

Volltextzugriff (PDF)

Mantle Cell Lymphoma of Mucosa‐Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study

HemaSphere, 2020-02, Vol.4 (1), p.e302-n/a

2020

Volltextzugriff (PDF)

Effects of chemotherapy dose reductions in overweight patients with acute myeloid leukaemia: A Danish nationwide cohort study

British journal of haematology, 2022-11, Vol.199 (4), p.539-548

2022

Volltextzugriff (PDF)

Temporal changes in survival among adult patients with acute myeloid leukaemia in the period 2000–2016: a Danish population‐based study

British journal of haematology, 2021-05, Vol.193 (3), p.482-487

2021

Volltextzugriff (PDF)

Routine Bone Marrow Biopsy Has Little or No Therapeutic Consequence for Positron Emission Tomography/Computed Tomography–Staged Treatment-Naive Patients With Hodgkin Lymphoma

Journal of clinical oncology, 2012-12, Vol.30 (36), p.4508-4514

2012

Volltextzugriff (PDF)

miR-155 as a Biomarker in B-Cell Malignancies

BioMed research international, 2016-01, Vol.2016 (2016), p.1-14

2016

Volltextzugriff (PDF)

Effectiveness of R-CHOP versus R-CHOEP for treatment of young patients with high-risk diffuse large B-cell lymphoma: A Danish observational population-based study

European journal of haematology, 2024-11, Vol.113 (5), p.641-650

2024

Volltextzugriff (PDF)

Outcome of limited‐stage peripheral T‐Cell lymphoma after CHOP(−like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group

American journal of hematology, 2023-03, Vol.98 (3), p.388-397

2023

Volltextzugriff (PDF)

Reply to H.J adams et al: “Is FDG‐PET/CT a sensitive and specific method for the detection of extranodal involvement in diffuse large B‐cell lymphoma?”

American journal of hematology, 2016-02, Vol.91 (2), p.E2-E3

2016

Volltextzugriff (PDF)

Revisiting beta‐2 microglobulin as a prognostic marker in diffuse large B‐cell lymphoma

Cancer medicine (Malden, MA), 2024-06, Vol.13 (12), p.e7239-n/a

2024

Volltextzugriff (PDF)

A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient Care

HemaSphere, 2023-03, Vol.7 (3), p.e842-n/a

2023

Volltextzugriff (PDF)

A prognostic model integrating PET‐derived metrics and image texture analyses with clinical risk factors from GOYA

EJHaem, 2022-05, Vol.3 (2), p.406-414

2022

Volltextzugriff (PDF)

P081: Treatment‐related circulatory diseases and mortality in Hodgkin lymphoma patients using multi‐state modelling and relative survival

HemaSphere, 2022-10, Vol.6 (Suppl), p.37-37

2022

Volltextzugriff (PDF)

PET/CT for Staging; Past, Present, and Future

Seminars in nuclear medicine, 2018-01, Vol.48 (1), p.4-16

2018

Volltextzugriff (PDF)

T065: Reproduction patterns among Classical Hodgkin Lymphoma Survivors Treated with BEACOPP and ABVD in Sweden, Denmark, and Norway

HemaSphere, 2022-10, Vol.6 (Suppl), p.30-30

2022

Volltextzugriff (PDF)

P074: Long‐Term Cause‐Specific Mortality in Hodgkin Lymphoma Patients – A Nationwide Danish Cohort Study

HemaSphere, 2022-10, Vol.6 (Suppl), p.34-34

2022

Volltextzugriff (PDF)

Outcomes among non-Western immigrant patients and Danish-born patients with acute myeloid Leukaemia: A Danish population-based cohort study

British journal of haematology, 2024-10

2024

Volltextzugriff (PDF)

1 – 25 von 159

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(154)
Mit Volltextzugriff
(141)

Publikationsform

Sprache

Englisch
(157)
Dänisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(81)
Life Sciences & Biomedicine
(77)
Hematology
(63)
Humans
(56)
Female
(33)
Male
(32)
Medicin Och Hälsovetenskap
(32)
Oncology
(32)
Adult
(30)
Aged
(30)
Lymphoma
(28)
Middle Aged
(28)
Prognosis
(24)
Patients
(20)
Aged, 80 And Over
(18)
Retrospective Studies
(18)
Adolescent
(16)
Denmark - Epidemiology
(16)
Young Adult
(16)
Lymphoma, Large B-Cell, Diffuse - Drug Therapy
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Pre‐treatment total metabolic tumour volumes in lymphoma: Does quantity matter?

Bone health and glucocorticoid‐containing lymphoma therapy — a review of risk factors and preventative measures

Late relapses in Hodgkin lymphoma – should we search for the needle in the haystack?

Routine imaging for disease surveillance in follicular lymphoma—To comfort the patients or their doctors?

Mantle cell lymphoma — where precision medicine based on response‐adapted treatment strategies could show its full worth

Long‐term cause‐specific mortality in adolescent and young adult Hodgkin lymphoma patients treated with contemporary regimens—A nationwide Danish cohort study

Primary gastric diffuse large B‐cell lymphoma: A multicentre retrospective study

Detecting deviations from the efficacy and safety results of single‐arm trials using real‐world data: The case of a CAR‐T cell therapy in B‐cell lymphoma

Mantle Cell Lymphoma of Mucosa‐Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study

Effects of chemotherapy dose reductions in overweight patients with acute myeloid leukaemia: A Danish nationwide cohort study

Real-world outcomes following third or subsequent lines of therapy: A Danish population-based study on 189 patients with relapsed/refractory large B-cell lymphomas

Temporal changes in survival among adult patients with acute myeloid leukaemia in the period 2000–2016: a Danish population‐based study

Routine Bone Marrow Biopsy Has Little or No Therapeutic Consequence for Positron Emission Tomography/Computed Tomography–Staged Treatment-Naive Patients With Hodgkin Lymphoma

miR-155 as a Biomarker in B-Cell Malignancies

Effectiveness of R-CHOP versus R-CHOEP for treatment of young patients with high-risk diffuse large B-cell lymphoma: A Danish observational population-based study

Outcome of limited‐stage peripheral T‐Cell lymphoma after CHOP(−like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group

Reply to H.J adams et al: “Is FDG‐PET/CT a sensitive and specific method for the detection of extranodal involvement in diffuse large B‐cell lymphoma?”

Revisiting beta‐2 microglobulin as a prognostic marker in diffuse large B‐cell lymphoma

A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient Care

A prognostic model integrating PET‐derived metrics and image texture analyses with clinical risk factors from GOYA

P081: Treatment‐related circulatory diseases and mortality in Hodgkin lymphoma patients using multi‐state modelling and relative survival

PET/CT for Staging; Past, Present, and Future

T065: Reproduction patterns among Classical Hodgkin Lymphoma Survivors Treated with BEACOPP and ABVD in Sweden, Denmark, and Norway

P074: Long‐Term Cause‐Specific Mortality in Hodgkin Lymphoma Patients – A Nationwide Danish Cohort Study

Outcomes among non-Western immigrant patients and Danish-born patients with acute myeloid Leukaemia: A Danish population-based cohort study

Suchergebnisse filtern